IP Library Granted Patent US 7,186,711
Granted Patent B2
US 7,186,711 · App. 10/622,068 · Granted Mar 6, 2007

Flumazenil for the treatment of cocaine dependency

Assignee: Hythiam, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,186,711
App. No.
10/622,068
Granted
Mar 6, 2007
Kind
B2
Abstract

The invention relates to the use of flumazenil to produce a medicament for the treatment of cocaine dependency. The flumazenil can be administered sequentially in small quantities at short intervals until a therapeutically effective quantity for the treatment of cocaine dependency has been administered.

Claims (18)

1. A method for treating cocaine dependency, comprising adminstering therapeutically effective amount of flumazenil to a human patient in need of such treatment, wherein the amount is effective to treat cocaine dependency.

2. The method of claim 1 , wherein the flumazenil is administered at time intervals of between about one and about fifteen minutes.

3. The method of claim 1 , wherein the flumazenil is administered in quantities between about 0.1 and about 0.3 mg.

4. The method of claim 1 , wherein the flumazenil is administered at time intervals of between about one and about fifteen minutes in quantities between about 0.1 and about 0.3 mg.

5. The method of claim 1 , wherein the effective amount of flumazenil is between about 1.5 and about 2.5 mg/day.

6. The method of claim 1 , wherein about 0.2 mg of flumazenil is administered sequentially at intervals of about 3 minutes.

7. The method of claim 1 , wherein the flumazenil is administered orally or parenterally.

8. The method of claim 7 , wherein the parenteral administration of flumazenil is intravenous administration.

9. The method of claim 1 , wherein the flumazenil is administered before, during or after treatment with an additional agent.

10. The method of claim 9 , wherein the additional agent is clomethiazole.

11. The method of claim 9 , wherein the additional agent is selected from the group consisting of Vitamin B Complex, Piracetam, vitamins, minerals, proteins, amino acids, disulfiram, fluoxetine, and combinations thereof.

12. The method of claim 1 , wherein the flumazenil is administered under sedation.

13. The method of claim 1 , wherein the administration of flumazenil reduces the desire to use cocaine.

14. A method for treating cocaine dependency, comprising administering a therapeutically effective amount of flumazenil to a human patient in need of such treatment, wherein the flumazenil is administered at time intervals of between about one and about fifteen minutes in quantities between about 0.1 and about 0.3 mg, wherein the amount is effective to treat cocaine dependency.

15. The method of claim 14 , wherein the effective amount of fiumazenil is between about 1.5 and about 2.5 mg/day.

16. The method of claim 14 , wherein the administration of flumazenil reduces the desire to use cocaine.

17. The method of claim 1 wherein the therapeutically effective amount of flumazenil is about 2 mg/day.

18. The method of claim 14 wherein the therapeutically effective amount of flumazenil is about 2 mg/day.

Assignments (9)
SECURITY INTEREST Recorded Aug 15, 2022
From: ONTRAK, INC.(F.K.A. CATASYS, INC., F.K.A. HYTHIAM, INC.); LD ACQUISITION HOLDINGS, INC.; LIFEDOJO INC.
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 060806/0473 →
RELEASE OF SECURITY INTEREST Recorded Jul 29, 2022
From: GOLDMAN SACHS SPECIALTY LENDING GROUP, L.P., AS COLLATERAL AGENT
To: ONTRAK, INC. (FORMERLY KNOWN AS CATASYS, INC.)
Reel/Frame 060672/0554 →
SECURITY INTEREST Recorded Feb 10, 2020
From: HYTHIAM, INC (N/K/A CATASYS, INC.)
To: GOLDMAN SACHS SPECIALTY LENDING GROUP, L.P.
Reel/Frame 051767/0204 →
RELEASE OF SECURITY INTEREST Recorded Oct 24, 2019
From: HIGHBRIDGE MSF INTERNATIONAL LTD F/K/A HIGHBRIDGE INTERNATIONAL LLC
To: CATASYS, INC. F/K/A HYTHIAM, INC.
Reel/Frame 050817/0175 →
CORRECTIVE ASSIGNMENT TO CORRECT THE NATURE OF THE CONVEYANCE OF THE ASSIGNMENT PREVIOUSLY RECORDED ON REEL 018824 FRAME 0619. ASSIGNOR(S) HEREBY CONFIRMS THE NATURE OF THE CONVEYANCE IS THE GRANTING OF A SECURITY INTEREST RATHER THAN THE TRANSFER OF OWNERSHIP. Recorded Nov 6, 2007
From: HYTHIAM, INC.
To: HIGHBRIDGE INTERNATIONAL LLC, AS AGENT C/O HIGHBRIDGE CAPITAL MANAGEMENT, LLC
Reel/Frame 020075/0814 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 30, 2007
From: HYTHIAM, INC.
To: HIGHBRIDGE INTERNATIONAL LLC, AS AGENT C/O HIGHBRIDGE CAPITAL MANAGEMENT, LLC
Reel/Frame 018824/0619 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 1, 2005
From: IBANEZ, JUAN JOSE LEGARDA
To: HYTHIAM, INC.
Reel/Frame 016832/0912 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 1, 2005
From: IBANEZ, JUAN JOSE LEGARDA
To: HYNTHIAM, INC.
Reel/Frame 016864/0414 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2003
From: IBANEZ, JUAN JOSE LEGARDA
To: HYTHIAM INC.
Reel/Frame 015594/0324 →
Continuity (1)
Related Publication 20060122219A1 · Jun 8, 2006